General MedicationsINJECTIONStandard
DANTRIUM
DANTROLENE SODIUM
Standard Dose
20MG/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview DANTRIUM is listed in Drugs@FDA under application 018264 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DANTROLENE SODIUM Form and strength INJECTABLE;INJECTION - 20MG/VIAL Sponsor PH HEALTH Submission history Latest submission status date: 2024-04-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview DANTRIUM is listed in Drugs@FDA under application 018264 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DANTROLENE SODIUM Form and strength INJECTABLE;INJECTION - 20MG/VIAL Sponsor PH HEALTH Submission history Latest submission status date: 2024-04-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.